RS53990B1 - Jedinjenja sa antibakterijskom aktivnošću protiv clostridium-a - Google Patents
Jedinjenja sa antibakterijskom aktivnošću protiv clostridium-aInfo
- Publication number
- RS53990B1 RS53990B1 RS20150318A RSP20150318A RS53990B1 RS 53990 B1 RS53990 B1 RS 53990B1 RS 20150318 A RS20150318 A RS 20150318A RS P20150318 A RSP20150318 A RS P20150318A RS 53990 B1 RS53990 B1 RS 53990B1
- Authority
- RS
- Serbia
- Prior art keywords
- compounds
- pharmaceutically acceptable
- formula
- compound
- tautomer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10171842 | 2010-08-04 | ||
| PCT/EP2011/063434 WO2012017030A1 (en) | 2010-08-04 | 2011-08-04 | Compounds with antibacterial activity against clostridium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS53990B1 true RS53990B1 (sr) | 2015-10-30 |
Family
ID=43125618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20150318A RS53990B1 (sr) | 2010-08-04 | 2011-08-04 | Jedinjenja sa antibakterijskom aktivnošću protiv clostridium-a |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8618100B2 (enExample) |
| EP (1) | EP2601193B1 (enExample) |
| JP (1) | JP5886285B2 (enExample) |
| KR (1) | KR101499368B1 (enExample) |
| CN (1) | CN103038234B (enExample) |
| AR (1) | AR082472A1 (enExample) |
| AU (1) | AU2011287584B2 (enExample) |
| BR (1) | BR112013003675A8 (enExample) |
| CA (1) | CA2805358C (enExample) |
| CL (1) | CL2013000331A1 (enExample) |
| CO (1) | CO6680629A2 (enExample) |
| CY (1) | CY1116238T1 (enExample) |
| DK (1) | DK2601193T3 (enExample) |
| EA (1) | EA021567B1 (enExample) |
| ES (1) | ES2538998T3 (enExample) |
| HR (1) | HRP20150467T1 (enExample) |
| ME (1) | ME02061B (enExample) |
| MX (1) | MX2013001246A (enExample) |
| NZ (1) | NZ605850A (enExample) |
| PH (1) | PH12013500219A1 (enExample) |
| PL (1) | PL2601193T3 (enExample) |
| PT (1) | PT2601193E (enExample) |
| RS (1) | RS53990B1 (enExample) |
| SG (1) | SG187175A1 (enExample) |
| SI (1) | SI2601193T1 (enExample) |
| TW (1) | TWI498330B (enExample) |
| WO (1) | WO2012017030A1 (enExample) |
| ZA (1) | ZA201300432B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9079935B2 (en) | 2012-08-13 | 2015-07-14 | The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas | Reducing risk of contracting Clostridium-difficile associated disease |
| US20180000793A1 (en) * | 2015-02-06 | 2018-01-04 | Ernesto Abel-Santos | Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis |
| GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
| KR101769204B1 (ko) * | 2015-08-04 | 2017-08-17 | 씨제이헬스케어 주식회사 | 크로마놀 유도체의 신규한 제조방법 |
| US12220421B2 (en) | 2021-09-09 | 2025-02-11 | The Boards Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las | Inhibitors of C. difficile spore germination |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101652140B (zh) * | 2006-09-26 | 2013-07-10 | 克莱斯通公司 | 具有抗菌活性的对映体化合物 |
| US8658670B2 (en) * | 2006-09-26 | 2014-02-25 | Crestone, Inc. | Methods and compounds for treatment of clostridium based infection |
| WO2008039639A2 (en) | 2006-09-26 | 2008-04-03 | Crestone, Inc. | Substituted thienopyridone compounds with antibacterial activity |
-
2011
- 2011-08-03 AR ARP110102808A patent/AR082472A1/es unknown
- 2011-08-03 TW TW100127482A patent/TWI498330B/zh not_active IP Right Cessation
- 2011-08-04 PL PL11740921T patent/PL2601193T3/pl unknown
- 2011-08-04 US US13/809,238 patent/US8618100B2/en not_active Expired - Fee Related
- 2011-08-04 MX MX2013001246A patent/MX2013001246A/es not_active Application Discontinuation
- 2011-08-04 AU AU2011287584A patent/AU2011287584B2/en not_active Ceased
- 2011-08-04 NZ NZ605850A patent/NZ605850A/en not_active IP Right Cessation
- 2011-08-04 JP JP2013522249A patent/JP5886285B2/ja not_active Expired - Fee Related
- 2011-08-04 DK DK11740921.9T patent/DK2601193T3/en active
- 2011-08-04 EA EA201270817A patent/EA021567B1/ru not_active IP Right Cessation
- 2011-08-04 EP EP11740921.9A patent/EP2601193B1/en active Active
- 2011-08-04 PT PT117409219T patent/PT2601193E/pt unknown
- 2011-08-04 CA CA2805358A patent/CA2805358C/en not_active Expired - Fee Related
- 2011-08-04 RS RS20150318A patent/RS53990B1/sr unknown
- 2011-08-04 CN CN201180037487.5A patent/CN103038234B/zh not_active Expired - Fee Related
- 2011-08-04 ME MEP-2015-40A patent/ME02061B/me unknown
- 2011-08-04 PH PH1/2013/500219A patent/PH12013500219A1/en unknown
- 2011-08-04 ES ES11740921.9T patent/ES2538998T3/es active Active
- 2011-08-04 SI SI201130439T patent/SI2601193T1/sl unknown
- 2011-08-04 KR KR1020137002738A patent/KR101499368B1/ko not_active Expired - Fee Related
- 2011-08-04 BR BR112013003675A patent/BR112013003675A8/pt not_active IP Right Cessation
- 2011-08-04 WO PCT/EP2011/063434 patent/WO2012017030A1/en not_active Ceased
- 2011-08-04 SG SG2013005202A patent/SG187175A1/en unknown
- 2011-08-04 HR HRP20150467TT patent/HRP20150467T1/hr unknown
-
2013
- 2013-01-16 ZA ZA2013/00432A patent/ZA201300432B/en unknown
- 2013-02-01 CL CL2013000331A patent/CL2013000331A1/es unknown
- 2013-02-01 CO CO13019560A patent/CO6680629A2/es active IP Right Grant
-
2015
- 2015-04-30 CY CY20151100392T patent/CY1116238T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60221684T2 (de) | Antibiotika mit doppelwirkung | |
| CA2664588C (en) | Enantiomeric fused-pyridinone compounds with antibacterial activity | |
| NO343376B1 (no) | 8-metoksy-9H-isotiazolo[5,4-b]kinolin-3,4-dioner, farmasøytisk preparater omfattende slike samt slike forbindelser og preparater for anvendelse ved behandling eller forhindring av infeksjoner | |
| EP2601193B1 (en) | Compounds with antibacterial activity against clostridium | |
| MXPA06001645A (es) | Isotiazoloquinolonas y compuestos relacionados como agentes anti-infecciosos. | |
| AU2015353077B2 (en) | Novel cystobactamides | |
| US8114888B2 (en) | Isothiazoloquinolones and related compounds as anti-infective agents | |
| WO2016007837A1 (en) | Carbonyl linked bicyclic heteroaryl antibiotic tolerance inhibitors | |
| US7973050B2 (en) | Enantiomeric compounds with antibacterial activity | |
| HK1180690B (en) | Compounds with antibacterial activity against clostridium | |
| MX2007005731A (es) | 8a, 9-dihidro-4a-h-isotiazolo [5,4-b] quinolina-3, 4-diomas y compuestos relacionados como agentes anti-infeccion. | |
| Podunavac-Kuzmanović et al. | Antimicrobial activity of cobalst (II) complexes with 2-aminobenzimidazole derivatives | |
| MX2008001344A (es) | 8-metoxi-9h-isotiazolo[5,4-b]quinolin-3,4-dionas y compuestos relacionados como agentes anti-infecciosos |